A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker? UpDoc’s CEO wouldn’t say whether generative AI in the company’s diabetes app makes treatment decisions

https://www.statnews.com/2026/07/02/fda-clearance-raises-questions-updoc-use-generative-ai-diabetes-treatment/ By Mario AguilarJuly 2, 2026 Health Tech Correspondent